Histogen to explore strategic options, shares up
** Shares of drug developer Histogen Inc HSTO.O rise about
33% to 97 cents in after hours trading
** Co to commence a process to explore strategic
alternatives
** Says paused development activities to preserve remaining
resources and extend cash runway
** Adds, does not intend to make further disclosures on
strategic review process unless a specific course of action is
approved by the board
** YTD stock down 12.3%
(Reporting by Vaibhav Sadhamta)
((Vaibhav.Sadhamta@thomsonreuters.com;))
Recent news on Histogen
See all newsBrief: Histogen Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Histogen Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution
Histogen Inc expected to post a loss of 90 cents a share - Earnings Preview
Histogen to explore strategic options, shares up